Radiosurgery Systems Market By Type (Gamma Knife system, Linear accelerator systems, Proton beam therapy), By Condition (Brain Tumors, Spine Tumors), By End User (Hospitals, Academic and Research institute): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global radiosurgery systems market was valued at $2,095.2 million in 2021, and is projected to reach $3,979.2 million by 2031, registering a CAGR of 6.7% from 2022 to 2031. An extremely accurate type of therapeutic radiology is radiosurgery, often known as stereotactic radiosurgery. Despite the name surgery, which implies actual surgery, radiosurgery is a single radiation therapy session that mimics the effects of a surgical procedure. Radiosurgery is a minimally invasive procedure that treats tumors and other issues in the brain, neck, lungs, liver, spine, and other areas of the body by using a large number of precisely focused radiation beams. Furthermore, stereotactic radiosurgery harms the DNA of the targeted cells, just like other radiation treatments do. Tumors then contract as the damaged cells lose their capacity to procreate.
Radiosurgery can be used to treat many conditions in the brain such as blood vessel disorders like arteriovenous malformation, trigeminal neuralgia, epilepsy and other. Mainly radiosurgery is used in primary brain tumor which includes pituitary tumor, meningioma, glioma, acoustic neuroma, hemangioblastoma, pediatric brain tumor, metastatic tumors and others. Moreover, radiosurgery is used to treat cancer disease.
The radiosurgery systems market is driven by rise in prevalence of cancer, technological advancement in development of radiosurgery systems, rise in the number of product launch and product approval for radiosurgery system. For instance, according to World Cancer Research Fund International, it was reported that 18,094,716 cancer cases were diagnosed over the globe. Moreover, according to World Health Organization, (WHO), in 2020, approximately 2.26 million new breast cancer cases were diagnosed worldwide. In addition, rise in the number of brain cancer, brain tumor and spinal cord tumor increases the demand of radiosurgery systems for treatment purpose. For instance, according to World Cancer Research Fund International, it was reported that 308,102 brain, central nervous system cancer cases were diagnosed over the globe.
The global radiosurgery systems market is predicted to develop as more patients battle brain tumors, which cause increase in the shift of consumer preference toward minimally invasive and non-invasive techniques. The use of minimally invasive radiosurgery is supported by a number of advantages, including quicker healing, lower morbidity and mortality, and shorter hospital stays.
Geriatric population is more susceptible to chronic diseases. Rise in number of geriatric populations increases the demand of radiosurgery systems for cancer treatment. Thus, this factor contributes to drive the growth of radiosurgery systems market. In addition, Governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2020 to 2019, reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for in radiosurgery systems application in different disease treatment, thereby boosting the market growth. On the other hand, high cost associated with radiosurgery systems and side effects of radiosurgery attributes to hinder market growth.
The radiosurgery systems market is segmented on the basis of type, condition, end user and region. On the basis of type the market is segmented into gamma knife system, linear accelerator systems and proton beam therapy. On the condition market is segmented into brain tumors and spine tumor. Brain tumor is further bifurcated into malignant and non-malignant. Malignant segment further sub-categorized into Meningioma, pituitary tumor and others. Non-malignant further sub categorized into Glioblastoma, Anaplastic astrocytoma and others. On the end user, market is bifurcated into hospitals and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global radiosurgery systems market include Accuray Incorporated, Elekta AB, Atrium Health, Avocure, Brain LAB, Integra Life Sciences Holding Corp, Ion Beam Applications SA, Medtronic, Mevion Medical Systems, Inc., Nordion Inc., Reflexion Medical, Siemens (Varian Medical Systems), Summit Cancer Centers, ViewRay, Vision RT, Xcision Medical Systems, ZAP surgical System Inc.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the radiosurgery systems market analysis from 2021 to 2031 to identify the prevailing radiosurgery systems market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the radiosurgery systems market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global radiosurgery systems market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Linear accelerator systems
Proton beam therapy
Gamma Knife system
By Condition
Brain Tumors
Type
Malignant
Non malignant
Spine Tumors
By End User
Hospitals
Academic and Research institute
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
ACCURAY INCORPORATED
Elekta AB
Atrium Health
Avocure
Brainlab
Integra LifeSciences Holding Corp
Ion Beam Applications SA
Medtronic
Mevion Medical Systems, Inc.
Nordion Inc.
RefleXion Medical
Siemens (Varian Medical Systems)
Summit Cancer Centers
ViewRay
vision rt ltd
Xcision Medical Systems
ZAP surgical System Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: RADIOSURGERY SYSTEMS MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Gamma Knife system
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Linear accelerator systems
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Proton beam therapy
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: RADIOSURGERY SYSTEMS MARKET, BY CONDITION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Brain Tumors
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Brain Tumors Radiosurgery Systems Market by Type
- 5.3 Spine Tumors
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: RADIOSURGERY SYSTEMS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Academic and Research institute
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: RADIOSURGERY SYSTEMS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Condition
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Condition
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Condition
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Condition
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Condition
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Condition
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Condition
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Condition
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Condition
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Condition
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Condition
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Condition
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Condition
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Condition
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Condition
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Condition
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Condition
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Condition
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Condition
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Condition
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 South Africa
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Condition
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 Saudi Arabia
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Condition
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Condition
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 ACCURAY INCORPORATED
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Elekta AB
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Atrium Health
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Avocure
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Brainlab
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Integra LifeSciences Holding Corp
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Ion Beam Applications SA
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Medtronic
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Mevion Medical Systems, Inc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Nordion Inc.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 RefleXion Medical
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Siemens (Varian Medical Systems)
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Summit Cancer Centers
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 ViewRay
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 vision rt ltd
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Xcision Medical Systems
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 ZAP surgical System Inc.
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. RADIOSURGERY SYSTEMS MARKET SIZE, FOR GAMMA KNIFE SYSTEM, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. RADIOSURGERY SYSTEMS MARKET FOR GAMMA KNIFE SYSTEM, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. RADIOSURGERY SYSTEMS MARKET SIZE, FOR LINEAR ACCELERATOR SYSTEMS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. RADIOSURGERY SYSTEMS MARKET FOR LINEAR ACCELERATOR SYSTEMS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. RADIOSURGERY SYSTEMS MARKET SIZE, FOR PROTON BEAM THERAPY, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. RADIOSURGERY SYSTEMS MARKET FOR PROTON BEAM THERAPY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 9. RADIOSURGERY SYSTEMS MARKET SIZE, FOR BRAIN TUMORS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. RADIOSURGERY SYSTEMS MARKET FOR BRAIN TUMORS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. GLOBAL BRAIN TUMORS RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 12. RADIOSURGERY SYSTEMS MARKET SIZE, FOR SPINE TUMORS, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. RADIOSURGERY SYSTEMS MARKET FOR SPINE TUMORS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 14. GLOBAL RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 15. RADIOSURGERY SYSTEMS MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. RADIOSURGERY SYSTEMS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. RADIOSURGERY SYSTEMS MARKET SIZE, FOR ACADEMIC AND RESEARCH INSTITUTE, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. RADIOSURGERY SYSTEMS MARKET FOR ACADEMIC AND RESEARCH INSTITUTE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. RADIOSURGERY SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. NORTH AMERICA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 21. NORTH AMERICA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 22. NORTH AMERICA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 23. NORTH AMERICA RADIOSURGERY SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. U.S. RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 25. U.S. RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 26. U.S. RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 27. CANADA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 28. CANADA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 29. CANADA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 30. MEXICO RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 31. MEXICO RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 32. MEXICO RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 33. EUROPE RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 34. EUROPE RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 35. EUROPE RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 36. EUROPE RADIOSURGERY SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. GERMANY RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 38. GERMANY RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 39. GERMANY RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 40. FRANCE RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 41. FRANCE RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 42. FRANCE RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 43. UK RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 44. UK RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 45. UK RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 46. ITALY RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 47. ITALY RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 48. ITALY RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 49. SPAIN RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. SPAIN RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 51. SPAIN RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 52. REST OF EUROPE RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 53. REST OF EUROPE RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 54. REST OF EUROPE RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 56. ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 57. ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 58. ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 59. CHINA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 60. CHINA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 61. CHINA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 62. JAPAN RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 63. JAPAN RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 64. JAPAN RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. INDIA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 66. INDIA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 67. INDIA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 68. AUSTRALIA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. AUSTRALIA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 70. AUSTRALIA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 71. SOUTH KOREA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. SOUTH KOREA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 73. SOUTH KOREA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 74. REST OF ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. REST OF ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 76. REST OF ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 77. LAMEA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 78. LAMEA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 79. LAMEA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 80. LAMEA RADIOSURGERY SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 81. BRAZIL RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 82. BRAZIL RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 83. BRAZIL RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. SOUTH AFRICA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 85. SOUTH AFRICA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 86. SOUTH AFRICA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. SAUDI ARABIA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 88. SAUDI ARABIA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 89. SAUDI ARABIA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 90. REST OF LAMEA RADIOSURGERY SYSTEMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 91. REST OF LAMEA RADIOSURGERY SYSTEMS MARKET, BY CONDITION, 2021-2031 ($MILLION)
- TABLE 92. REST OF LAMEA RADIOSURGERY SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 93.ACCURAY INCORPORATED: COMPANY SNAPSHOT
- TABLE 94.ACCURAY INCORPORATED: OPERATING SEGMENTS
- TABLE 95.ACCURAY INCORPORATED: PRODUCT PORTFOLIO
- TABLE 96.ACCURAY INCORPORATED: NET SALES,
- TABLE 97.ACCURAY INCORPORATED: KEY STRATERGIES
- TABLE 98.ELEKTA AB: COMPANY SNAPSHOT
- TABLE 99.ELEKTA AB: OPERATING SEGMENTS
- TABLE 100.ELEKTA AB: PRODUCT PORTFOLIO
- TABLE 101.ELEKTA AB: NET SALES,
- TABLE 102.ELEKTA AB: KEY STRATERGIES
- TABLE 103.ATRIUM HEALTH: COMPANY SNAPSHOT
- TABLE 104.ATRIUM HEALTH: OPERATING SEGMENTS
- TABLE 105.ATRIUM HEALTH: PRODUCT PORTFOLIO
- TABLE 106.ATRIUM HEALTH: NET SALES,
- TABLE 107.ATRIUM HEALTH: KEY STRATERGIES
- TABLE 108.AVOCURE: COMPANY SNAPSHOT
- TABLE 109.AVOCURE: OPERATING SEGMENTS
- TABLE 110.AVOCURE: PRODUCT PORTFOLIO
- TABLE 111.AVOCURE: NET SALES,
- TABLE 112.AVOCURE: KEY STRATERGIES
- TABLE 113.BRAINLAB: COMPANY SNAPSHOT
- TABLE 114.BRAINLAB: OPERATING SEGMENTS
- TABLE 115.BRAINLAB: PRODUCT PORTFOLIO
- TABLE 116.BRAINLAB: NET SALES,
- TABLE 117.BRAINLAB: KEY STRATERGIES
- TABLE 118.INTEGRA LIFESCIENCES HOLDING CORP: COMPANY SNAPSHOT
- TABLE 119.INTEGRA LIFESCIENCES HOLDING CORP: OPERATING SEGMENTS
- TABLE 120.INTEGRA LIFESCIENCES HOLDING CORP: PRODUCT PORTFOLIO
- TABLE 121.INTEGRA LIFESCIENCES HOLDING CORP: NET SALES,
- TABLE 122.INTEGRA LIFESCIENCES HOLDING CORP: KEY STRATERGIES
- TABLE 123.ION BEAM APPLICATIONS SA: COMPANY SNAPSHOT
- TABLE 124.ION BEAM APPLICATIONS SA: OPERATING SEGMENTS
- TABLE 125.ION BEAM APPLICATIONS SA: PRODUCT PORTFOLIO
- TABLE 126.ION BEAM APPLICATIONS SA: NET SALES,
- TABLE 127.ION BEAM APPLICATIONS SA: KEY STRATERGIES
- TABLE 128.MEDTRONIC: COMPANY SNAPSHOT
- TABLE 129.MEDTRONIC: OPERATING SEGMENTS
- TABLE 130.MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 131.MEDTRONIC: NET SALES,
- TABLE 132.MEDTRONIC: KEY STRATERGIES
- TABLE 133.MEVION MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
- TABLE 134.MEVION MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
- TABLE 135.MEVION MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
- TABLE 136.MEVION MEDICAL SYSTEMS, INC.: NET SALES,
- TABLE 137.MEVION MEDICAL SYSTEMS, INC.: KEY STRATERGIES
- TABLE 138.NORDION INC.: COMPANY SNAPSHOT
- TABLE 139.NORDION INC.: OPERATING SEGMENTS
- TABLE 140.NORDION INC.: PRODUCT PORTFOLIO
- TABLE 141.NORDION INC.: NET SALES,
- TABLE 142.NORDION INC.: KEY STRATERGIES
- TABLE 143.REFLEXION MEDICAL: COMPANY SNAPSHOT
- TABLE 144.REFLEXION MEDICAL: OPERATING SEGMENTS
- TABLE 145.REFLEXION MEDICAL: PRODUCT PORTFOLIO
- TABLE 146.REFLEXION MEDICAL: NET SALES,
- TABLE 147.REFLEXION MEDICAL: KEY STRATERGIES
- TABLE 148.SIEMENS (VARIAN MEDICAL SYSTEMS): COMPANY SNAPSHOT
- TABLE 149.SIEMENS (VARIAN MEDICAL SYSTEMS): OPERATING SEGMENTS
- TABLE 150.SIEMENS (VARIAN MEDICAL SYSTEMS): PRODUCT PORTFOLIO
- TABLE 151.SIEMENS (VARIAN MEDICAL SYSTEMS): NET SALES,
- TABLE 152.SIEMENS (VARIAN MEDICAL SYSTEMS): KEY STRATERGIES
- TABLE 153.SUMMIT CANCER CENTERS: COMPANY SNAPSHOT
- TABLE 154.SUMMIT CANCER CENTERS: OPERATING SEGMENTS
- TABLE 155.SUMMIT CANCER CENTERS: PRODUCT PORTFOLIO
- TABLE 156.SUMMIT CANCER CENTERS: NET SALES,
- TABLE 157.SUMMIT CANCER CENTERS: KEY STRATERGIES
- TABLE 158.VIEWRAY: COMPANY SNAPSHOT
- TABLE 159.VIEWRAY: OPERATING SEGMENTS
- TABLE 160.VIEWRAY: PRODUCT PORTFOLIO
- TABLE 161.VIEWRAY: NET SALES,
- TABLE 162.VIEWRAY: KEY STRATERGIES
- TABLE 163.VISION RT LTD: COMPANY SNAPSHOT
- TABLE 164.VISION RT LTD: OPERATING SEGMENTS
- TABLE 165.VISION RT LTD: PRODUCT PORTFOLIO
- TABLE 166.VISION RT LTD: NET SALES,
- TABLE 167.VISION RT LTD: KEY STRATERGIES
- TABLE 168.XCISION MEDICAL SYSTEMS: COMPANY SNAPSHOT
- TABLE 169.XCISION MEDICAL SYSTEMS: OPERATING SEGMENTS
- TABLE 170.XCISION MEDICAL SYSTEMS: PRODUCT PORTFOLIO
- TABLE 171.XCISION MEDICAL SYSTEMS: NET SALES,
- TABLE 172.XCISION MEDICAL SYSTEMS: KEY STRATERGIES
- TABLE 173.ZAP SURGICAL SYSTEM INC.: COMPANY SNAPSHOT
- TABLE 174.ZAP SURGICAL SYSTEM INC.: OPERATING SEGMENTS
- TABLE 175.ZAP SURGICAL SYSTEM INC.: PRODUCT PORTFOLIO
- TABLE 176.ZAP SURGICAL SYSTEM INC.: NET SALES,
- TABLE 177.ZAP SURGICAL SYSTEM INC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.RADIOSURGERY SYSTEMS MARKET SEGMENTATION
- FIGURE 2.RADIOSURGERY SYSTEMS MARKET,2021-2031
- FIGURE 3.RADIOSURGERY SYSTEMS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.RADIOSURGERY SYSTEMS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.RADIOSURGERY SYSTEMS MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GAMMA KNIFE SYSTEM RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF LINEAR ACCELERATOR SYSTEMS RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PROTON BEAM THERAPY RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 16.RADIOSURGERY SYSTEMS MARKET,BY CONDITION,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF BRAIN TUMORS RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SPINE TUMORS RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 19.RADIOSURGERY SYSTEMS MARKET,BY END USER,2021(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND RESEARCH INSTITUTE RADIOSURGERY SYSTEMS MARKET,2021-2031(%)
- FIGURE 22.RADIOSURGERY SYSTEMS MARKET BY REGION,2021
- FIGURE 23.U.S. RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 24.CANADA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 25.MEXICO RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 26.GERMANY RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 27.FRANCE RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 28.UK RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 29.ITALY RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 30.SPAIN RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 31.REST OF EUROPE RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 32.CHINA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 33.JAPAN RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 34.INDIA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 35.AUSTRALIA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 36.SOUTH KOREA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 37.REST OF ASIA-PACIFIC RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 38.BRAZIL RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH AFRICA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 40.SAUDI ARABIA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 41.REST OF LAMEA RADIOSURGERY SYSTEMS MARKET,2021-2031($MILLION)
- FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 46.COMPETITIVE DASHBOARD
- FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 48.ACCURAY INCORPORATED.: NET SALES ,($MILLION)
- FIGURE 49.ELEKTA AB.: NET SALES ,($MILLION)
- FIGURE 50.ATRIUM HEALTH.: NET SALES ,($MILLION)
- FIGURE 51.AVOCURE.: NET SALES ,($MILLION)
- FIGURE 52.BRAINLAB.: NET SALES ,($MILLION)
- FIGURE 53.INTEGRA LIFESCIENCES HOLDING CORP.: NET SALES ,($MILLION)
- FIGURE 54.ION BEAM APPLICATIONS SA.: NET SALES ,($MILLION)
- FIGURE 55.MEDTRONIC.: NET SALES ,($MILLION)
- FIGURE 56.MEVION MEDICAL SYSTEMS, INC..: NET SALES ,($MILLION)
- FIGURE 57.NORDION INC..: NET SALES ,($MILLION)
- FIGURE 58.REFLEXION MEDICAL.: NET SALES ,($MILLION)
- FIGURE 59.SIEMENS (VARIAN MEDICAL SYSTEMS).: NET SALES ,($MILLION)
- FIGURE 60.SUMMIT CANCER CENTERS.: NET SALES ,($MILLION)
- FIGURE 61.VIEWRAY.: NET SALES ,($MILLION)
- FIGURE 62.VISION RT LTD.: NET SALES ,($MILLION)
- FIGURE 63.XCISION MEDICAL SYSTEMS.: NET SALES ,($MILLION)
- FIGURE 64.ZAP SURGICAL SYSTEM INC..: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook